Back to GLENMARK
Clear

Board Meetings for GLENMARK

Detailed list of historic and upcoming board meetings.

SymbolCompanyMeeting DatePurposeDescriptionLinks
GLENMARKGlenmark Pharmaceuticals Limited29 May 2026Board Meeting IntimationGLENMARK PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 29-May-2026 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2026 and Dividend.
PDFXBRL
GLENMARKGlenmark Pharmaceuticals Limited29 May 2026Financial Results/DividendTo consider and approve the financial results for the period ended March 31, 2026 and dividend
PDF
GLENMARKGlenmark Pharmaceuticals Limited30 Jan 2026Financial ResultsTo consider and approve the financial results for the period ended December 31, 2025
PDF
GLENMARKGlenmark Pharmaceuticals Limited30 Jan 2026Board Meeting IntimationGLENMARK PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 30-Jan-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2025 .
PDFXBRL
GLENMARKGlenmark Pharmaceuticals Limited14 Nov 2025Board Meeting IntimationGlenmark Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 14-Nov-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2025 .
PDFXBRL
GLENMARKGlenmark Pharmaceuticals Limited14 Nov 2025Financial ResultsTo consider and approve the financial results for the period ended September 30, 2025
PDF
GLENMARKGlenmark Pharmaceuticals Limited26 Sept 2025Board Meeting IntimationGlenmark Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 26-Sep-2025 to consider Dividend.
PDFXBRL
GLENMARKGlenmark Pharmaceuticals Limited26 Sept 2025DividendTo consider and approve payment of interim dividend
PDF
GLENMARKGlenmark Pharmaceuticals Limited14 Aug 2025Board Meeting IntimationGLENMARK PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 14-Aug-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2025 .
PDFXBRL
GLENMARKGlenmark Pharmaceuticals Limited14 Aug 2025Financial ResultsTo consider and approve the financial results for the period ended June 30, 2025
PDF
GLENMARKGlenmark Pharmaceuticals Limited23 May 2025Financial Results/DividendTo consider and approve the financial results for the period ended March 31, 2025 and dividend
PDF
GLENMARKGlenmark Pharmaceuticals Limited23 May 2025Board Meeting IntimationGLENMARK PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 23-May-2025 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2025 and Dividend.
PDFXBRL
GLENMARKGlenmark Pharmaceuticals Limited14 Feb 2025Board Meeting IntimationGLENMARK PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 14-Feb-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2024 .
PDFXBRL
GLENMARKGlenmark Pharmaceuticals Limited14 Feb 2025Financial ResultsTo consider and approve the financial results for the period ended December 31, 2024
PDF
GLENMARKGlenmark Pharmaceuticals Limited14 Nov 2024Board Meeting IntimationGLENMARK PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 14-Nov-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2024 .
PDF
Showing page 1 of 8 (110 total items)
Next